一名多发性骨髓瘤患者发生的硼替佐米相关结肠黏膜炎 - Suppr

Bortezomib-related colon mucositis in a multiple myeloma patient.

作者信息

Siniscalchi Agostina, Tendas Andrea, Ales Micaela, Fratoni Stefano, Cupelli Luca, Dentamaro Teresa, Scaramucci Laura, Giovannini Marco, Caravita Tommaso, Santeusanio Giuseppe, Niscola Pasquale, de Fabritiis Paolo

出版信息

Support Care Cancer. 2009 Apr;17(4):325-7. doi: 10.1007/s00520-008-0573-3. Epub 2009 Jan 27.

DOI:10.1007/s00520-008-0573-3

PMID:19172306

Abstract

摘要

相似文献

Support Care Cancer. 2009 Apr;17(4):325-7. doi: 10.1007/s00520-008-0573-3. Epub 2009 Jan 27.

[Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure].

Gan To Kagaku Ryoho. 2011 Feb;38(2):237-41.

Bortezomib-induced acute pancreatitis in a patient with multiple myeloma.

Leuk Lymphoma. 2014 Jun;55(6):1404-5. doi: 10.3109/10428194.2013.831850. Epub 2013 Aug 28.

Hyperlipidemia in a myeloma patient after bortezomib treatment.

Leuk Res. 2010 Sep;34(9):e250. doi: 10.1016/j.leukres.2010.03.025. Epub 2010 Apr 3.

Optimizing bortezomib treatment in patients with relapsed multiple myeloma.

Clin Adv Hematol Oncol. 2006 May;4(5):4-5; discussion 8; suppl 13.

Bortezomib increases survival of patients with relapsed multiple myeloma.

Health News. 2005 Sep;11(9):9.

Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma.

J Clin Oncol. 2007 Aug 1;25(22):3380-1. doi: 10.1200/JCO.2006.10.0164.

Lenalidomide for bortezomib-resistant multiple myeloma.

Nat Rev Clin Oncol. 2010 Sep;7(9). doi: 10.1038/nrclinonc.2010.31-c1; author reply doi:10.1038/nrclinonc.2010.31-c3.

Severe pulmonary complications after bortezomib treatment for multiple myeloma: an unrecognized pulmonary vasculitis?

Leuk Res. 2007 Jul;31(7):1027-8. doi: 10.1016/j.leukres.2006.09.015. Epub 2006 Nov 28.

Bortezomib-induced Sweet syndrome.

Br J Haematol. 2005 Oct;131(2):142. doi: 10.1111/j.1365-2141.2005.05636.x.

引用本文的文献

Gut inflammation induced by drugs: Can pathology help to differentiate from inflammatory bowel disease?

United European Gastroenterol J. 2022 Jun;10(5):451-464. doi: 10.1002/ueg2.12242. Epub 2022 May 28.

本文引用的文献

Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment.

J Support Oncol. 2007 Jun;5(6):259-67.

Bortezomib-induced paralytic ileus is a potential gastrointestinal side effect of this first-in-class anticancer proteasome inhibitor.

Eur J Gastroenterol Hepatol. 2007 Jul;19(7):599-601. doi: 10.1097/MEG.0b013e32811ebffe.

Mucositis in patients with hematologic malignancies: an overview.

Haematologica. 2007 Feb;92(2):222-31. doi: 10.3324/haematol.10232.

Pseudomembranous colitis following bortezomib therapy in a myeloma patient.

Acta Haematol. 2007;117(4):211-4. doi: 10.1159/000098699. Epub 2007 Jan 18.

Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies.

Nat Clin Pract Oncol. 2006 Jul;3(7):374-87. doi: 10.1038/ncponc0555.

Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies.

Support Care Cancer. 2006 Sep;14(9):890-900. doi: 10.1007/s00520-006-0040-y. Epub 2006 Apr 8.

Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage.

Support Care Cancer. 2006 Jul;14(7):713-31. doi: 10.1007/s00520-005-0004-7. Epub 2006 Feb 2.

A practical update on the use of bortezomib in the management of multiple myeloma.

Oncologist. 2006 Jan;11(1):51-61. doi: 10.1634/theoncologist.11-1-51.

Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal function.

Cancer. 2005 Mar 15;103(6):1195-200. doi: 10.1002/cncr.20888.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Bortezomib-related colon mucositis in a multiple myeloma patient.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献